| For: | Nakai M, Morikawa K, Hosoda S, Yoshida S, Kubo A, Tokuchi Y, Kitagataya T, Yamada R, Ohara M, Sho T, Suda G, Ogawa K, Sakamoto N. Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma. World J Hepatol 2022; 14(7): 1480-1494 [PMID: 36158914 DOI: 10.4254/wjh.v14.i7.1480] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i7/1480.htm |
| Number | Citing Articles |
| 1 |
Annalisa Cespiati, Daniel Smith, Rosa Lombardi, Anna Ludovica Fracanzani. The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes. Cancers 2024; 16(13): 2315 doi: 10.3390/cancers16132315
|
| 2 |
Kyle R Stephens, Megan Wilson, Manting Xu, Jeremy T Gaskins, Gina Genova, Robert C G Martin II. Mac-2 binding protein glycosylation isomer as a novel serum biomarker for recurrence in hepatocellular carcinoma. World Journal of Gastroenterology 2026; 32(5): 113693 doi: 10.3748/wjg.v32.i5.113693
Abstract(26) |
Core Tip(17) |
Full Article(HTML)(104)
|
Full Article with Cover (PDF)-3575K(44)
|
Audio-738K(4)
|
Peer-Review Report-223K(13)
|
Answering Reviewers-73K(9)
|
Supplementary Material-107K(10)
|
Full Article (PDF)-2049K(18)
|
Full Article (XML)-98K(12)
|
Times Cited (0)
|
Total Visits (547)
|
Open
|
| 3 |
Ludong Zhao. Combining serum biomarkers and MRI radiomics to predict treatment outcome after thermal ablation in hepatocellular carcinoma. American Journal of Translational Research 2025; 17(3): 2031 doi: 10.62347/TFRF1430
|
| 4 |
Hiroki Nishikawa, Tomohiro Nishikawa, Akira Fukuda, Kosuke Ushiro, Masahiro Matsui, Saori Onishi, Soo Ki Kim, Akira Asai. Impact of the FIB4 Index on Pre-sarcopenia in Patients with Metabolic-dysfunction Associated Steatotic Liver Disease. Internal Medicine 2025; 64(21): 3078 doi: 10.2169/internalmedicine.5250-25
|
